PDS Biotechnology Corporation
PDSB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $23 | $28 | $29 | $11 |
| G&A Expenses | $0 | $15 | $12 | $10 |
| SG&A Expenses | $14 | $15 | $12 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $36 | $43 | $42 | $21 |
| Operating Income | -$36 | -$43 | -$42 | -$21 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$38 | -$44 | -$42 | -$21 |
| Tax Expense | -$1 | -$1 | -$1 | -$5 |
| Net Income | -$38 | -$43 | -$41 | -$17 |
| % Margin | – | – | – | – |
| EPS | -1.03 | -1.39 | -1.43 | -0.66 |
| % Growth | 25.9% | 2.8% | -116.7% | – |
| EPS Diluted | -1.03 | -1.39 | -1.43 | -0.66 |
| Weighted Avg Shares Out | 36 | 31 | 29 | 26 |
| Weighted Avg Shares Out Dil | 36 | 31 | 29 | 26 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $1 | $0 |
| Interest Expense | $5 | $4 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$34 | -$40 | -$41 | -$21 |
| % Margin | – | – | – | – |